News and Comments


  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...


  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...

Recent Postings



Human Genome Sciences (HGSI) Galena (GALE) Editas (EDIT) Benlysta (belimumab) KERYX (KERX) SUNESIS PHARMACEUTICALS (SNSS) ACADIA (ACAD) Trastuzumab-DM1 Sangamo (SGMO) PORTOLA (PTLA) Global Cell Therapeutics (GBT) Dendreon (DNDN) NEKTAR (NKTR)) ARGOS (ARGS) TOKAI (TKAOI) ADVENTRIX (ANX) Zerenex Bellicum (BLCM) Dynavax (DVAX) Mirati Therapeutics (MRTX) Theravance (THRX) IDERA (IDRA) Ionis (IONS) GlaxoSmithKline (GSK) NOVOCURE (NVCR) Cytokinetics (CYTK) Prolor Biotech (PBTH) Ridaforolimus JOUNCE THERAPEUTICS (JNCE) AGOS (ARGS) NANTKWEST (NK) Rapamune GUARDIAN HEALTH Inovio (INO) Anadys (ANDS) Anacor (ANAC) CEMPRA (CEMP) ISIS (ISIS) Pluristem (PSTI) OncoCyte (OCX) RenenxBio (RGNX) CompuGen (CGEN) Aimmune Therapeutics (AIMT) Multiple Myeloma Herceptin Regeneron (REGN) Revlimid (lenolidamide) Intercept (ICPT) Human Longevity (HLI) REGULUS (RGLS) Agenus (AGEN) Roche (RHHBY) C4 Therapeutics Advaxis (ADXS) Agenus (AGEN Theravance Bio Pharma (TBPH) Sanofi-Aventis (SAN) Array Pharmaceuticals (ARRY) AERIE PHARMACEUTICALS Illumina (ILMN) Genentech Abbott Laboratories (ABT) Seattle Genetics (SGEN) Telaprevir Vertex (VRTX) Jazz Pharmaceuticals (JAZZ) Onyx (ONXX) JUNO (JUNO) Auspex (ASPX) VANDA (VNDA) ZALTRAP™ Adaptimmune (ADAP) AstraZeneca (AZN) KITE (KITE) BIOMARIN (BMRN) Endometrial Cancer Valeant Pharmaceuticals International (VRX) Intrexon (XON) Bristol-Myers Squibb (BMY) Sarepta (SRPT) ARCA (ABIO) OSI (OSIP) ImmunoGen (IMGN) INNOVIVA (INVA) Alder Biopharmaceuticals (ALDR) PTC Therapeutics (PTCT) Merck (MRK) Spike Therapeutics (ONCE) Amgen (AMGN) Ariad (ARIA) Velcade (bortezomib) Elan (ELN) Prosensa (RNA) Gilead (GILD) Vitae Pharmaceuticals (VTAE) Ocular Therapeutix (OCUL) HALOZYME (HALO) CRISPR Therapeutics (CRSP) SYNTA (SNTA) ABBVIE (ABBV) Exelixis (EXEL) Biogen Idec (BIIB) Sanofi (SNA) SERES THERAPEUTICS (MCRB) Incyte (INCY) Biocryst (BCRX) Idenix (IDIX) Intermune (ITMN) Roche (ROCHE) Sanofi (SNY) Alnylam (ALNY) Tysabri LEXICON (LXRX) Sequenom (SQNM) Xoma (XOMA) galapagos (GLPG) MODERNA Micromet (MITI) Ziofpharm (ZIOP)